Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turoctocog alfa pegol in previously treated Chinese severe hemophilia A patients
CTR20211836Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of octocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Jul 2021; status: completed.
02
Drugs
octocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20211836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211836.